SpaceX slips 7% despite Oppenheimer target hike and new buy rating

SpaceX fell nearly 7% after a sharp post-IPO surge, with the stock sliding from a record $225.64 to $191.82 amid profit-taking, valuation concerns, and upcoming lock-up expiration risk. The company also disclosed a $4.9 billion net loss in 2025 and a $4.28 billion loss in Q1 2026, though Oppenheimer raised its target to $250 and Arete initiated coverage at $401. Broader markets were higher and the Fed held rates at 3.50%–3.75%, but those factors did not stop the selloff.

Analysis

The tape is signaling classic post-IPO de-risking, but the more important issue is that the float is still tiny relative to the implied growth narrative. That makes the stock extremely vulnerable to supply shocks around the lock-up window: even modest selling pressure can overwhelm fundamentals for weeks, especially if early holders use a high multiple to de-risk after the first liquidity event. In that setup, the first trade is usually not about intrinsic value but about whether incremental marginal buyers are still price-insensitive enough to absorb supply.

The acquisition of an AI software asset also changes the equity story from a single-platform “must-own” compounder into a capital-allocation debate. If investors start valuing the company on sum-of-parts rather than pure narrative premium, the market may demand proof that adjacent bets monetize faster than the dilution and execution drag they create. That tends to compress multiple expansion in the near term, even if the strategic logic is sound over a multi-year horizon.

The contrarian angle is that the selloff may be sharper than the underlying fundamentals justify if the street is underestimating operating leverage in the connectivity business and overestimating near-term dilution from the deal. But the burden of proof is now much higher: until there is evidence that new assets lift forward revenue per share, the stock is likely to trade like a crowded momentum name with binary supply overhangs rather than a clean growth compounder. The window where valuation can outrun fundamentals is closing, not opening.

Key Decisions for Investors

• Fade strength via short-dated put spreads into any rebound over the next 1-2 weeks; the setup favors elevated realized volatility and downside air pocket risk rather than orderly mean reversion.
• Avoid initiating fresh longs until after the August lock-up catalyst; if you must own it, size as a post-event entry only after daily volume normalizes and insider supply is digested.
• For relative value, pair a long in profitable mega-cap internet/platform exposure against a short in the stock to isolate sentiment and financing risk from broader AI-beta exposure; this reduces factor bleed if the market stays risk-on.
• If the stock breaks below the recent post-IPO low on volume, expect systematic selling to accelerate; use that as the trigger to add to the short or buy further downside convexity with 30-60 day tenor.
• Treat analyst-target chasing as a trap: upside to consensus can still exist, but the better risk/reward is waiting for a reset in implied volatility and a better entry after supply clears.